This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abe, T. Articles by Gutterman, D. D. Search for Related Content PubMed PubMed Citation Articles by Abe, T. Articles by Gutterman, D. D. Pubmed/NCBI databases Substance via MeSH

(Circulation. 1997;95:213-220.)
© 1997 American Heart Association, Inc.

Articles

Protective Role of Nerve Growth Factor Against Postischemic Dysfunction of Sympathetic Coronary Innervation

Toyohiko Abe, PhD, MD; Donald A. Morgan, BS; David D. Gutterman, MD

the Cardiovascular Center, University of Iowa College of Medicine and Veterans Affairs Medical Center, Iowa City.

Background Nerve growth factor (NGF) is produced rapidly in myocardium after brief myocardial ischemia. It contributes to the maintenance of neural integrity in several tissues. We examined the effect of exogenous and endogenous NGF on ischemia-induced dysfunction of cardiac sympathetic nerves.

Methods and Results In anesthetized dogs, bilateral stellate stimulation was performed, measuring changes in coronary vascular resistance (%CVR) before and after release of either a 7- or 15-minute occlusion of the left anterior descending coronary artery (LAD). NGF (10 ng·kg^-1·min^-1, n=5) or vehicle (n=6) was infused into the LAD in dogs during a 15-minute LAD occlusion. In separate experiments, antibody to NGF (anti-NGF, 2 ng·kg^-1·min^-1, n=5) or vehicle (n=6) was infused into dogs during a 7-minute LAD occlusion. After release of a 15-minute LAD occlusion, attenuation of the coronary constriction to stellate stimulation was seen in the vehicle group (30±3% to 15±1% increase in CVR, P<.05); however, no such reduction was seen in the group receiving NGF. A 7-minute LAD occlusion with reperfusion did not alter %CVR in the vehicle group (36±6% versus 37±7%, P=NS) but attenuated %CVR in the anti-NGF group (39±8% to 17±2%, P<.05).

Conclusions We conclude that exogenously infused and endogenously released NGF protects against postischemic neural stunning of sympathetic cardiac innervation.

Key Words: ischemia • peptides • nervous system, autonomic • circulation

This article has been cited by other articles:

				J. M. Canty Jr and J. A. Fallavollita Sympathetic Nerves and Myocyte Necrosis: More Than Meets the Eye Circ. Res., October 31, 2003; 93(9): 796 - 798. [Full Text] [PDF]

				M Matucci-Cerinic, R Giacomelli, A Pignone, M L Cagnoni, S Generini, R Casale, P Cipriani, A Del Rosso, P Tirassa, Y T Konttinen, et al. Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma) Ann Rheum Dis, May 1, 2001; 60(5): 487 - 494. [Abstract] [Full Text] [PDF]

				J. Pernow Adenosine as an important mediator of post-ischaemic neuronal stunning Cardiovasc Res, March 1, 2001; 49(4): 693 - 694. [Full Text] [PDF]

				V. Sanchis-Alfonso and E. Rosello-Sastre Immunohistochemical Analysis for Neural Markers of the Lateral Retinaculum in Patients with Isolated Symptomatic Patellofemoral Malalignment: A Neuroanatomic Basis for Anterior Knee Pain in the Active Young Patient Am. J. Sports Med., September 1, 2000; 28(5): 725 - 731. [Abstract] [Full Text] [PDF]

				S. De Santis, A. Pace, L. Bove, F. Cognetti, F. Properzi, M. Fiore, V. Triaca, A. Savarese, M. D. Simone, B. Jandolo, et al. Patients Treated with Antitumor Drugs Displaying Neurological Deficits Are Characterized by a Low Circulating Level of Nerve Growth Factor Clin. Cancer Res., January 1, 2000; 6(1): 90 - 95. [Abstract] [Full Text]